BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 23263025)

  • 41. Systemic antifungal therapy in pediatric practice.
    Marwaha RK; Maheshwari A
    Indian Pediatr; 1999 Oct; 36(10):1011-21. PubMed ID: 10745311
    [No Abstract]   [Full Text] [Related]  

  • 42. Pulmonary aspergillosis: recent advances.
    Thompson GR; Patterson TF
    Semin Respir Crit Care Med; 2011 Dec; 32(6):673-81. PubMed ID: 22167395
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antifungal serum concentration monitoring: an update.
    Goodwin ML; Drew RH
    J Antimicrob Chemother; 2008 Jan; 61(1):17-25. PubMed ID: 17999982
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Consumption of systemic antifungal agents among acute care hospitals in Catalonia (Spain), 2008-2013.
    Fondevilla E; Grau S; Mojal S; Palomar M; Matas L; Gudiol F;
    Expert Rev Anti Infect Ther; 2016; 14(1):137-44. PubMed ID: 26466197
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antifungals in Clinical Use and the Pipeline.
    Johnson MD
    Infect Dis Clin North Am; 2021 Jun; 35(2):341-371. PubMed ID: 34016281
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current status and future of antifungal therapy for systemic mycoses.
    Nosanchuk JD
    Recent Pat Antiinfect Drug Discov; 2006 Jan; 1(1):75-84. PubMed ID: 18221136
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment outcome of invasive mould disease after sequential exposure to azoles and liposomal amphotericin B.
    Cornely OA; Maertens J; Bresnik M; Ullmann AJ; Ebrahimi R; Herbrecht R
    J Antimicrob Chemother; 2010 Jan; 65(1):114-7. PubMed ID: 19887460
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications.
    Lyman CA; Walsh TJ
    Drugs; 1992 Jul; 44(1):9-35. PubMed ID: 1379913
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Management of invasive fungal infections in children].
    Blanche S; Dupont B
    Arch Pediatr; 2011 May; 18 Suppl 1():S1-2. PubMed ID: 21596281
    [No Abstract]   [Full Text] [Related]  

  • 50. [NEW ANTIFUNGAL DRUGS FOR PREVENTION AND TREATMENT OF VISCERAL MYCOSES].
    Pilmis B; Lortholary O; Lanternier FL
    Rev Prat; 2015 Dec; 65(10):1334-9. PubMed ID: 26979038
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Combination antifungal therapy for invasive fungal disease in children with hematologic disease].
    Qiu K; Deng L; Huang K; Guo H; Fang J; Xu H; Xue H; Li Y; Chen C; Zhou D
    Zhonghua Xue Ye Xue Za Zhi; 2015 Nov; 36(11):912-7. PubMed ID: 26632462
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics of antifungal agents in children.
    Watt K; Benjamin DK; Cohen-Wolkowiez M
    Early Hum Dev; 2011 Mar; 87 Suppl 1(Suppl 1):S61-5. PubMed ID: 21277714
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New and emerging options for management of invasive fungal diseases in paediatric patients.
    Groll AH; Körholz K; Holterhus M; Lehrnbecher T
    Mycoses; 2024 Jan; 67(1):e13654. PubMed ID: 37789721
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antifungal Agents: Spectrum of Activity, Pharmacology, and Clinical Indications.
    Nett JE; Andes DR
    Infect Dis Clin North Am; 2016 Mar; 30(1):51-83. PubMed ID: 26739608
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Potential of anidulafungin in combined therapy].
    Gadea I; Mensa J
    Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 14():51-5. PubMed ID: 19572435
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current options in antifungal pharmacotherapy.
    Mohr J; Johnson M; Cooper T; Lewis JS; Ostrosky-Zeichner L
    Pharmacotherapy; 2008 May; 28(5):614-45. PubMed ID: 18447660
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Treatment recommendations for invasive fungal disease in pediatric patients with cancer or blood disease].
    Tang S; ; ; ;
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):426-9. PubMed ID: 25190161
    [No Abstract]   [Full Text] [Related]  

  • 58. Use of amphotericin B with azole antifungal drugs: what are we doing?
    Sugar AM
    Antimicrob Agents Chemother; 1995 Sep; 39(9):1907-12. PubMed ID: 8540690
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinical pharmacology of antifungal compounds.
    Groll AH; Gea-Banacloche JC; Glasmacher A; Just-Nuebling G; Maschmeyer G; Walsh TJ
    Infect Dis Clin North Am; 2003 Mar; 17(1):159-91, ix. PubMed ID: 12751265
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fungal cell membrane-promising drug target for antifungal therapy.
    Sant DG; Tupe SG; Ramana CV; Deshpande MV
    J Appl Microbiol; 2016 Dec; 121(6):1498-1510. PubMed ID: 27667746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.